BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37864666)

  • 1. A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?
    Turchini J; Fuchs TL; Chou A; Sioson L; Clarkson A; Sheen A; Delbridge L; Glover A; Sywak M; Sidhu S; Gill AJ
    Endocr Pathol; 2023 Dec; 34(4):461-470. PubMed ID: 37864666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
    Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
    Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
    Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
    Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytological diagnosis of papillary thyroid carcinoma with tall cells on ThinPrep liquid-based cytology.
    Baum JE; Soong L; Scognamiglio T; Margolskee EM; Hoda RS; Rao R
    Diagn Cytopathol; 2019 Jun; 47(6):541-546. PubMed ID: 30648353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic clues indicating tall cell variants of papillary thyroid carcinoma in fine needle aspiration.
    Tanaka A; Hirokawa M; Higuchi M; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Diagn Cytopathol; 2019 May; 47(5):452-457. PubMed ID: 30582297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
    Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma.
    Beninato T; Scognamiglio T; Kleiman DA; Uccelli A; Vaca D; Fahey TJ; Zarnegar R
    Surgery; 2013 Dec; 154(6):1331-6; discussion 1336. PubMed ID: 24238051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
    Poma AM; Viola D; Macerola E; Proietti A; Molinaro E; De Vietro D; Elisei R; Materazzi G; Miccoli P; Basolo F; Ugolini C
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4109-e4117. PubMed ID: 34061965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
    Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
    Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease.
    Bongers PJ; Kluijfhout WP; Verzijl R; Lustgarten M; Vermeer M; Goldstein DP; Devon K; Rotstein LE; Asa SL; Brierley JD; Tsang RW; Ezzat S; Vriens MR; Mete O; Pasternak JD
    Ann Surg Oncol; 2019 Aug; 26(8):2533-2539. PubMed ID: 31115855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
    Dettmer MS; Schmitt A; Steinert H; Capper D; Moch H; Komminoth P; Perren A
    Endocr Relat Cancer; 2015 Jun; 22(3):419-29. PubMed ID: 25870252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary Thyroid Carcinomas with Tall Cell Features: An Intermediate Entity Between Classic and Tall Cell Subtypes.
    Bikas A; Wong K; Pappa T; Ahmadi S; Wakefield CB; Marqusee E; Xiang P; Altshuler B; Haase J; Barletta JA; Landa I; Alexander EK
    Thyroid; 2023 Jun; 33(6):697-704. PubMed ID: 36960703
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of fine-needle aspiration and core needle biopsies in the diagnosis of tall cell variant of papillary thyroid carcinoma.
    Ahn J; Jin M; Kim WG; Kim TY; Kim WB; Shong YK; Baek JH; Song DE; Jeon MJ
    Clin Endocrinol (Oxf); 2023 Jan; 98(1):110-116. PubMed ID: 35394662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
    Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A deep learning-based algorithm for tall cell detection in papillary thyroid carcinoma.
    Stenman S; Linder N; Lundin M; Haglund C; Arola J; Lundin J
    PLoS One; 2022; 17(8):e0272696. PubMed ID: 35944056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
    Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
    World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.
    Thomas A; Mittal N; Rane SU; Bal M; Patil A; Ankathi SK; Vaish R
    Head Neck Pathol; 2021 Dec; 15(4):1137-1146. PubMed ID: 33840044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.